Skip to main content
Top
Published in: World Journal of Surgery 5/2011

01-05-2011

Clinicopathological Features and Outcomes of Young Patients with Hepatocellular Carcinoma after Hepatectomy

Authors: Kazuki Takeishi, Ken Shirabe, Jun Muto, Takeo Toshima, Akinobu Taketomi, Yoshihiko Maehara

Published in: World Journal of Surgery | Issue 5/2011

Login to get access

Abstract

Background

There are few reports about hepatectomy for young patients with hepatocellular carcinoma (HCC), and the significance of resection for young patients remains unknown. The present study aimed to investigate retrospectively the clinicopathological features and outcomes after hepatectomy of young HCC patients.

Methods

Among 610 patients who underwent curative hepatectomy for HCC between January 1987 and December 2007, 13 patients younger than 40 years of age were defined as the young group. Because none of the young group had hepatitis C virus antibodies (HCVAb), 246 patients aged above 40 years without HCVAb were defined as the older group. The clinicopathological findings and outcomes after hepatectomy were compared between the two groups.

Results

In the young group, 7 patients had hepatitis B surface antigen and 3 other patients had hepatitis B core antibodies. The young group had better liver function but more advanced HCC, with a large tumor size and a high incidence of portal vein invasion compared with the older group. Major hepatectomy was more frequently chosen in the young group than in the older group. There was no significant difference in the incidences of postoperative complications. The overall survival tended to be better in the young group than in the older group (p = 0.057).

Conclusions

Hepatitis B virus-related HCC was common inthe younger group of patients reported here. Although the young patients had advanced HCC, there were no significant differences in the complication rate and the overall survival rate of the young and older groups. Aggressive hepatic resection for young patients would contribute to improved survival and should be recommended.
Literature
1.
go back to reference El-serag HB (2002) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35:S72–S78PubMedCrossRef El-serag HB (2002) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35:S72–S78PubMedCrossRef
3.
go back to reference Shiratori Y, Yoshida H, Omata M (2001) Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol 36:73–78PubMedCrossRef Shiratori Y, Yoshida H, Omata M (2001) Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol 36:73–78PubMedCrossRef
4.
go back to reference Kiyosawa K, Uemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17–S26PubMedCrossRef Kiyosawa K, Uemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17–S26PubMedCrossRef
5.
go back to reference Stroffolini T, Andreone P, Andriulli A et al (1998) Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29:944–953PubMedCrossRef Stroffolini T, Andreone P, Andriulli A et al (1998) Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29:944–953PubMedCrossRef
6.
go back to reference Cho SJ, Yoon JH, Hwang SS et al (2007) Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 22:1226–1231PubMedCrossRef Cho SJ, Yoon JH, Hwang SS et al (2007) Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 22:1226–1231PubMedCrossRef
7.
go back to reference Chen CH, Chang TT, Cheng KS et al (2006) Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 26:766–773PubMedCrossRef Chen CH, Chang TT, Cheng KS et al (2006) Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 26:766–773PubMedCrossRef
8.
go back to reference Aramaki M, Kawano K, Sasaki A et al (2005) Hepatocellular carcinoma in young adults. Hepatogastroenterology 52:1795–1797PubMed Aramaki M, Kawano K, Sasaki A et al (2005) Hepatocellular carcinoma in young adults. Hepatogastroenterology 52:1795–1797PubMed
9.
go back to reference Yamazaki Y, Kakizaki S, Sohara N et al (2007) Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci 52:1103–1107PubMedCrossRef Yamazaki Y, Kakizaki S, Sohara N et al (2007) Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci 52:1103–1107PubMedCrossRef
10.
go back to reference Ng IO, Ng MM, Lai EC et al (1996) Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 61:134–137PubMedCrossRef Ng IO, Ng MM, Lai EC et al (1996) Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 61:134–137PubMedCrossRef
11.
go back to reference Lam CM, Chan AO, Ho P et al (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients—implications for screening. Aliment Pharmacol Ther 19:771–777PubMedCrossRef Lam CM, Chan AO, Ho P et al (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients—implications for screening. Aliment Pharmacol Ther 19:771–777PubMedCrossRef
12.
go back to reference Chang PE, Ong WC, Lui HF et al (2008) Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 43:881–888PubMedCrossRef Chang PE, Ong WC, Lui HF et al (2008) Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 43:881–888PubMedCrossRef
13.
go back to reference Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellularcarcinoma. Br J Surg 85:195–198PubMedCrossRef Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellularcarcinoma. Br J Surg 85:195–198PubMedCrossRef
14.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef
15.
go back to reference Lack EE, Neace C, Vawter GF (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515PubMedCrossRef Lack EE, Neace C, Vawter GF (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515PubMedCrossRef
16.
go back to reference Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer. Second English edition. Kanehara, Tokyo Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer. Second English edition. Kanehara, Tokyo
17.
go back to reference Bruix J, Sherman M (2005) AASLD practice guideline: management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef Bruix J, Sherman M (2005) AASLD practice guideline: management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef
18.
go back to reference De Bac C, Stroffolini T, Gaeta GB et al (1994) Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 20:1225–1230PubMedCrossRef De Bac C, Stroffolini T, Gaeta GB et al (1994) Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 20:1225–1230PubMedCrossRef
19.
go back to reference Schoniger-Hekele M, Muller C, Kutilek M et al (2001) Hepatocellular carcinoma in central Europe: prognostic features and survival. Gut 48:103–109PubMedCrossRef Schoniger-Hekele M, Muller C, Kutilek M et al (2001) Hepatocellular carcinoma in central Europe: prognostic features and survival. Gut 48:103–109PubMedCrossRef
20.
go back to reference Kew MC (1981) Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1:366–369PubMedCrossRef Kew MC (1981) Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1:366–369PubMedCrossRef
21.
go back to reference Merican I, Guan R, Amarapuka D et al (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356–1361PubMedCrossRef Merican I, Guan R, Amarapuka D et al (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356–1361PubMedCrossRef
22.
go back to reference Lai CL, Yuen MF (2007) The natural history of chronic hepatitis B. J Viral Hepat 14(Suppl 1):6–10PubMed Lai CL, Yuen MF (2007) The natural history of chronic hepatitis B. J Viral Hepat 14(Suppl 1):6–10PubMed
23.
go back to reference Ko CY, Hsu HC, Shen MR et al (2008) Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex. J Biol Chem 283:30919–30932PubMedCrossRef Ko CY, Hsu HC, Shen MR et al (2008) Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex. J Biol Chem 283:30919–30932PubMedCrossRef
24.
go back to reference Agrawal S, Hofmann WK, Tidow N et al (2007) The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109:3895–3905PubMedCrossRef Agrawal S, Hofmann WK, Tidow N et al (2007) The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109:3895–3905PubMedCrossRef
25.
go back to reference Weber A, Boger R, Vick B et al (2010) Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 51:1226–1236PubMed Weber A, Boger R, Vick B et al (2010) Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 51:1226–1236PubMed
26.
go back to reference Fried M, Kalra J, Iardi CF et al (1987) Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia. Cancer 60:2548–2552PubMedCrossRef Fried M, Kalra J, Iardi CF et al (1987) Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia. Cancer 60:2548–2552PubMedCrossRef
27.
go back to reference Guariso G, Fiorio S, Altavilla G et al (1998) Congenital absence of the portal vein associated with nodular hyperplasia of the liver and cystic dysplasia of the kidney. Eur J Paediatr 157:287–290CrossRef Guariso G, Fiorio S, Altavilla G et al (1998) Congenital absence of the portal vein associated with nodular hyperplasia of the liver and cystic dysplasia of the kidney. Eur J Paediatr 157:287–290CrossRef
28.
go back to reference Matsuoka Y, Ohtomo K, Okubo T et al (1992) Congenital absence of the portal vein. Gastrointest Radiol 17:31–33PubMedCrossRef Matsuoka Y, Ohtomo K, Okubo T et al (1992) Congenital absence of the portal vein. Gastrointest Radiol 17:31–33PubMedCrossRef
29.
go back to reference Bannasch P (1996) Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. Prog Liver Dis 14:161–197PubMed Bannasch P (1996) Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. Prog Liver Dis 14:161–197PubMed
30.
go back to reference Tso PL, Bringaze WL 3rd, Dauterive AH et al (1987) Gastric carcinoma in the young. Cancer 59:1362–1365PubMedCrossRef Tso PL, Bringaze WL 3rd, Dauterive AH et al (1987) Gastric carcinoma in the young. Cancer 59:1362–1365PubMedCrossRef
31.
go back to reference de la Monte SM, Hutchins GM, Moore GW (1988) Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 19:529–534CrossRef de la Monte SM, Hutchins GM, Moore GW (1988) Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 19:529–534CrossRef
32.
go back to reference Theuer CP, Kurosaki T, Taylor TH et al (1998) Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 83:25–33PubMedCrossRef Theuer CP, Kurosaki T, Taylor TH et al (1998) Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 83:25–33PubMedCrossRef
33.
go back to reference Msika S, Benhamiche AM, Jouve JL et al (2000) Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 36:390–396PubMedCrossRef Msika S, Benhamiche AM, Jouve JL et al (2000) Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 36:390–396PubMedCrossRef
34.
go back to reference The Cancer of the Liver Italian Program (CLIP) investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755CrossRef The Cancer of the Liver Italian Program (CLIP) investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755CrossRef
35.
go back to reference Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38:207–215PubMedCrossRef Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38:207–215PubMedCrossRef
36.
go back to reference Huang ZQ, Xu LN, Yang T et al (2009) Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J 122:2268–2277PubMed Huang ZQ, Xu LN, Yang T et al (2009) Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J 122:2268–2277PubMed
37.
go back to reference Shimada M, Yamashita Y, Hamatsu T et al (2000) Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology 47:1095–1099PubMed Shimada M, Yamashita Y, Hamatsu T et al (2000) Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology 47:1095–1099PubMed
38.
go back to reference Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef
39.
go back to reference Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746PubMedCrossRef Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746PubMedCrossRef
40.
go back to reference Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801PubMedCrossRef Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801PubMedCrossRef
41.
go back to reference He J, Zeng ZC, Tang ZY et al (2009) Clinical features and prognostic factor in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 115:2710–2720PubMedCrossRef He J, Zeng ZC, Tang ZY et al (2009) Clinical features and prognostic factor in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 115:2710–2720PubMedCrossRef
Metadata
Title
Clinicopathological Features and Outcomes of Young Patients with Hepatocellular Carcinoma after Hepatectomy
Authors
Kazuki Takeishi
Ken Shirabe
Jun Muto
Takeo Toshima
Akinobu Taketomi
Yoshihiko Maehara
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1017-7

Other articles of this Issue 5/2011

World Journal of Surgery 5/2011 Go to the issue